-
-
-
-
-
-
-
Angion Provides Corporate Update and Reports Full Year 2021 Financial Results
-
-
-
-
-
-
-
Vifor Pharma and Angion report topline results from phase-III registration trial of ANG-3777 in kidney transplant patients at risk for delayed graft function
-
-
-
-
-
-
-
Angion Provides Corporate Update and Reports First Quarter 2021 Financial Results
-
-
-
-
-
-
-
Trading Radar for 12/16: Darden (DRI), Angeion (ANGN) Report
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

